Publications for Christopher Semsarian
Publications for Christopher
Semsarian
2016
Bagnall, R., Crompton, D., Petrovski, S., Lam,
L., Cutmore, C., Garry, S., Sadleir, L., Dibbens,
L., Cairns, A., Kivity, S., Duflou, J., Semsarian,
C., et al (2016). Exome-based analysis of cardiac
arrhythmia, respiratory control and epilepsy
genes in sudden unexpected death in epilepsy.
Annals of Neurology, 79(4), 522-534. <a
href="http://dx.doi.org/10.1002/ana.24596">[Mo
re Information]</a>
Burns, C., McGaughran, J., Davis, A.,
Semsarian, C., Ingles, J. (2016). Factors
influencing uptake of familial long QT syndrome
genetic testing. American Journal of Medical
Genetics. Part A, 170(2), 418-425. <a
href="http://dx.doi.org/10.1002/ajmg.a.37455">[
More Information]</a>
Ingles, J., Spinks, C., Yeates, L., McGeechan,
K., Kasparian, N., Semsarian, C. (2016).
Posttraumatic stressand prolonged grief after the
sudden cardiac death of a young relative. JAMA
Internal Medicine, 176(3), 402-405. <a
href="http://dx.doi.org/10.1001/jamainternmed.2
015.7808">[More Information]</a>
Semsarian, C., Ingles, J. (2016). Preventing
sudden cardiac death in athletes. BMJ, 353, 1-2.
<a
href="http://dx.doi.org/10.1136/bmj.i1270">[Mo
re Information]</a>
Orchard, J., Puranik, R., Semsarian, C., Orchard,
J., Samra, D., Duflou, J., Groenestein, P., Young,
M., Brukner, P., Kountouris, A. (2016).
Prevention of sudden cardiac death in cricketers.
Journal of Postgraduate Medicine Education
and Research, 50, 49-58. <a
href="http://dx.doi.org/10.5005/jp-journals-1002
8-1193">[More Information]</a>
Lim, W., Baumert, M., Kuklik, P., Ganesan, A.,
Lau, D., Tsoutsman, T., Semsarian, C., Sanders,
P., Saint, D. (2016). Slowed Atrial and
Atrioventricular Conduction and Depressed HRV
in a Murine Model of Hypertrophic
Cardiomyopathy. Clinical and Experimental
Pharmacology and Physiology, 43(1), 95-101. <a
href="http://dx.doi.org/10.1111/1440-1681.1249
8">[More Information]</a>
Sweeting, J., Ingles, J., Ball, K., Semsarian, C.
(2016). Sudden deaths during the largest
community running event in Australia: A 25-year
review. International Journal of Cardiology,
203, 1029-1031. <a
href="http://dx.doi.org/10.1016/j.ijcard.2015.11.
103">[More Information]</a>
Goldman, A., Behr, E., Semsarian, C., Bagnall,
R., Sisodiya, S., Cooper, P. (2016). Sudden
unexpected death in epilepsy genetics: Molecular
diagnostics and prevention. Epilepsia, 57(Suppl
1), 17-25. <a
href="http://dx.doi.org/10.1111/epi.13232">[Mo
re Information]</a>
2015
Ingles, J., Burns, C., Barratt, A., Semsarian, C.
(2015). Application of Genetic Testing in
Hypertrophic Cardiomyopathy for Preclinical
Disease Detection. Circulation: Cardiovascular
Genetics, 8(6), 852-859. <a
href="http://dx.doi.org/10.1161/CIRCGENETIC
S.115.001093">[More Information]</a>
Sweeting, J., Ingles, J., Ball, K., Semsarian, C.
(2015). Challenges of Exercise
Recommendations and Sports Participation in
Genetic Heart Disease Patients. Circulation
Cardiovascular Genetics, 8(1), 178-186. <a
href="http://dx.doi.org/10.1161/CIRCGENETIC
S.114.000784">[More Information]</a>
Padang, R., Bagnall, R., Tsoutsman, T., Bannon,
P., Semsarian, C. (2015). Comparative
transcriptome profiling in human bicuspid aortic
valve disease using RNA sequencing.
Physiological Genomics, 47(3), 75-87. <a
href="http://dx.doi.org/10.1152/physiolgenomics
.00115.2014">[More Information]</a>
Semsarian, C., Ingles, J. (2015). Determining
pathogenicity in cardiac genetic testing: Filling
in the blank spaces. Trends in Cardiovascular
Medicine, 25(7), 653-654. <a
href="http://dx.doi.org/10.1016/j.tcm.2015.03.00
4">[More Information]</a>
Ho, C., Lakdawala, N., Cirino, A., Lipshultz, S.,
Sparks, E., Abbasi, S., Kwong, R., Antman, E.,
Semsarian, C., Gonzalez, A., et al (2015).
Diltiazem Treatment for Pre-Clinical
Hypertrophic Cardiomyopathy Sarcomere
Mutation Carriers : A Pilot Randomized Trial to
Modify Disease Expression. JACC: Heart
Failure, 3(2), 180-188. <a
href="http://dx.doi.org/10.1016/j.jchf.2014.08.00
3">[More Information]</a>
Lam, L., Ingles, J., Turner, C., Kilborn, M.,
Bagnall, R., Semsarian, C. (2015). Exome
sequencing identifies a novel mutation in the
MYH6 gene in a family with early-onset sinus
node dysfunction, ventricular arrhythmias, and
cardiac arrest. HeartRhythm Case Reports, 1(3),
141-145. <a
href="http://dx.doi.org/10.1016/j.hrcr.2015.01.02
2">[More Information]</a>
Padang, R., Ganigara, M., O'Meagher, S.,
Grieve, S., Bannon, P., Celermajer, D., Jeremy,
R., Semsarian, C., Puranik, R. (2015). Feasibility
of using real-time CMR imaging to evaluate
Publications for Christopher Semsarian
acute thoracic aortic response to exercise.
International Journal of Cardiology, 197,
306-308. <a
href="http://dx.doi.org/10.1016/j.ijcard.2015.05.
187">[More Information]</a>
Semsarian, C., Sweeting, J., Ackerman, M.
(2015). Sudden cardiac death in athletes. BMJ,
350, 1-7. <a
href="http://dx.doi.org/10.1136/bmj.h1218">[M
ore Information]</a>
Semsarian, C., Ingles, J. (2015). Genetics of
HCM and Role of Genetic Testing. In Srihari S.
Naidu (Eds.), Hypertrophic Cardiomyopathy,
(pp. 77-84). London: Springer-Verlag. <a
href="http://dx.doi.org/10.1007/978-1-4471-495
6-9_6">[More Information]</a>
Semsarian, C., Sweeting, J., Ackerman, M.
(2015). Sudden cardiac death in athletes. British
Journal of Sports Medicine, 49(15), 1017-1023.
<a
href="http://dx.doi.org/10.1136/bjsports-2015-h1
218rep">[More Information]</a>
Choudhary, P., Hsu, C., Grieve, S., Smillie, C.,
Singarayar, S., Semsarian, C., Richmond, D.,
Muthurangu, V., Celermajer, D., Puranik, R.
(2015). Improving the diagnosis of LV
non-compaction with cardiac magnetic resonance
imaging. International Journal of Cardiology,
181, 430-436. <a
href="http://dx.doi.org/10.1016/j.ijcard.2014.12.
053">[More Information]</a>
Semsarian, C., Ingles, J., Wilde, A. (2015).
Sudden cardiac death in the young: the molecular
autopsy and a practical approach to surviving
relatives. European Heart Journal, 36(21),
1290-1296. <a
href="http://dx.doi.org/10.1093/eurheartj/ehv063
">[More Information]</a>
Semsarian, C., Ingles, J. (2015). Letter by
Semsarian and Ingles regarding article, A
randomized trial of social media from
Circulation"". Circulation, 131(13), e394. <a
href="http://dx.doi.org/10.1161/CIRCULATION
AHA.114.014628">[More Information]</a>
Semsarian, C., Ingles, J., Maron, M., Maron, B.
(2015). New Perspectives on the Prevalence of
Hypertrophic Cardiomyopathy. Journal of the
American College of Cardiology, 65(12),
1249-1254. <a
href="http://dx.doi.org/10.1016/j.jacc.2015.01.01
9">[More Information]</a>
Earle, N., Ingles, J., Bagnall, R., Gray, B.,
Crawford, J., Smith, W., Shelling, A., Love, D.,
Semsarian, C., Skinner, J. (2015). NOS1AP
polymorphisms modify QTc interval duration but
not cardiac arrest risk in hypertrophic
cardiomyopathy. Journal of Cardiovascular
Electrophysiology.
Tully, I., Atherton, J., Hunt, L., Ingles, J.,
Semsarian, C., McGaughran, J. (2015). Rarity
and phenotypic heterogeneity provide challenges
in the diagnosis of Andersen-Tawil syndrome:
Two cases presenting with ECGs mimicking
catecholaminergic polymorphic ventricular
tachycardia (CPVT). International Journal of
Cardiology, 201, 473-475. <a
href="http://dx.doi.org/10.1016/j.ijcard.2015.07.
069">[More Information]</a>
Ingles, J., Johnson, R., Sarina, T., Yeates, L.,
Burns, C., Gray, B., Ball, K., Semsarian, C.
(2015). Social determinants of health in the
setting of hypertrophic cardiomyopathy.
International Journal of Cardiology, 184(1),
743-749. <a
href="http://dx.doi.org/10.1016/j.ijcard.2015.03.
070">[More Information]</a>
Feng, J., Hickling, S., Nedkoff, L., Knuiman, M.,
Semsarian, C., Ingles, J., Briffa, T. (2015).
Sudden cardiac death rates in an Australian
population: A data linkage study. Australian
Health Review, 39(5), 561-567. <a
href="http://dx.doi.org/10.1071/AH14226">[Mo
re Information]</a>
Wu, J., Seco, M., Medi, C., Semsarian, C.,
Richmond, D., Dearani, J., Schaff, H., Byrom,
M., Bannon, P. (2015). Surgery for hypertrophic
cardiomyopathy. Biophysical Reviews, 7(1),
117-125. <a
href="http://dx.doi.org/10.1007/s12551-014-015
3-3">[More Information]</a>
Orchard, J., Orchard, J., Neubeck, A., Semsarian,
C. (2015). The Use of Smartphone ECGS in
Sports and Exercise Medicine. Sport Health,
33(2), 38-41.
2014
Burns, C., Semsarian, C., Ingles, J. (2014).
Access, uptake and communication of genetic
test results in Australian families with long QT
syndrome (LQTS). Heart, Lung and Circulation,
23(S2), e7.
Gray, B., Semsarian, C., Sy, R. (2014). Brugada
Syndrome: A Heterogeneous Disease with a
Common ECG Phenotype? Journal of
Cardiovascular Electrophysiology, 25(4),
450-456. <a
href="http://dx.doi.org/10.1111/jce.12366">[Mor
e Information]</a>
Sweeting, J., Semsarian, C. (2014). Cardiac
abnormalities and sudden infant death syndrome.
Paediatric Respiratory Reviews, 15(4), 301-306.
<a
href="http://dx.doi.org/10.1016/j.prrv.2014.09.00
6">[More Information]</a>
Driscoll, E., Ingles, J., Semsarian, C. (2014).
Publications for Christopher Semsarian
Clinical and genetic characteristics of
hypertrophic cardiomyopathy patients with
end-stage disease: A registry-based study. Heart,
Lung and Circulation, 23(S2), e8-e9.
Puranik, R., Gray, B., Lackey, H., Yeates, L.,
Parker, G., Duflou, J., Semsarian, C. (2014).
Comparison of conventional autopsy and
magnetic resonance imaging in determining the
cause of sudden death in the young. Journal of
Cardiovascular Magnetic Resonance, 16(1),
1-11. <a
href="http://dx.doi.org/10.1186/1532-429X-16-4
4">[More Information]</a>
Ingles, J., Semsarian, C. (2014). Conveying a
probabilistic genetic test result to families with
an inherited heart disease. Heart Rhythm, 11(6),
1073-1078. <a
href="http://dx.doi.org/10.1016/j.hrthm.2014.03.
017">[More Information]</a>
Kozlovski, J., Ingles, J., Connell, V., Hunt, L.,
McGaughran, J., Turner, C., Davis, A., Sy, R.,
Semsarian, C. (2014). Delay to diagnosis
amongst patients with catecholaminergic
polymorphic ventricular tachycardia.
International Journal of Cardiology, 176(3),
1402-1404. <a
href="http://dx.doi.org/10.1016/j.ijcard.2014.08.
020">[More Information]</a>
Padang, R., Dennis, M., Semsarian, C., Bannon,
P., Tanous, D., Celermajer, D., Puranik, R.
(2014). Detection of Serious Complications by
MR Imaging in Asymptomatic Young Adults
with Repaired Coarctation of the Aorta. Heart,
Lung and Circulation, 23(4), 332-338. <a
href="http://dx.doi.org/10.1016/j.hlc.2013.10.05
5">[More Information]</a>
Das K, J., Ingles, J., Bagnall, R., Semsarian, C.
(2014). Determining pathogenicity of genetic
variants in hypertrophic cardiomyopathy:
importance of periodic reassessment. Genetics in
Medicine, 16(4), 286-293. <a
href="http://dx.doi.org/10.1038/gim.2013.138">[
More Information]</a>
Bagnall, R., Das K, J., Duflou, J., Semsarian, C.
(2014). Exome analysis–based molecular
autopsy in cases of sudden unexplained death in
the young. Heart Rhythm, 11(4), 655-662. <a
href="http://dx.doi.org/10.1016/j.hrthm.2014.01.
017">[More Information]</a>
Bagnall, R., Molloy, L., Kalman, J., Semsarian,
C. (2014). Exome sequencing identifies a
mutation in the ACTN2 gene in a family with
idiopathic ventricular fibrillation, left ventricular
noncompaction, and sudden death. BMC Medical
Genetics, 15, 1-9. <a
href="http://dx.doi.org/10.1186/s12881-014-009
9-0">[More Information]</a>
Bagnall, R., Crompton, D., Cutmore, C., Regan,
B., Berkovic, S., Scheffer, I., Semsarian, C.
(2014). Genetic analysis of PHOX2B in sudden
unexpected death in epilepsy cases. Neurology,
83(11), 1018-1021. <a
href="http://dx.doi.org/10.1212/WNL.00000000
00000781">[More Information]</a>
Brunklaus, A., Ellis, R., Reavey, E., Semsarian,
C., Zuberi, S. (2014). Genotype phenotype
associations across the voltage-gated sodium
channel family. Journal of Medical Genetics,
51(10), 650-658. <a
href="http://dx.doi.org/10.1136/jmedgenet-2014102608">[More Information]</a>
Maron, B., Ommen, S., Semsarian, C., Spirito,
P., Olivotto, I., Maron, M. (2014). Hypertrophic
cardiomyopathy: Present and future, with
translation into contemporary cardiovascular
medicine. Journal of the American College of
Cardiology, 64(1), 83-99. <a
href="http://dx.doi.org/10.1016/j.jacc.2014.05.00
3">[More Information]</a>
Bagnall, R., Ingles, J., Semsarian, C. (2014).
Illumina TruSight Cardiomyopathy Sequencing
Panel: Application to hypertrophic
cardiomyopathy. Heart, Lung and Circulation,
23(S2), e5.
Femia, G., Hsu, C., Singarayar, S., Sy, R.,
Kilborn, M., Parker, G., McGuire, M.,
Semsarian, C., Puranik, R. (2014). Impact of new
task force criteria in the diagnosis of
arrhythmogenic right ventricular
cardiomyopathy. International Journal of
Cardiology, 171(2), 179-183. <a
href="http://dx.doi.org/10.1016/j.ijcard.2013.11.
092">[More Information]</a>
Gray, B., McGuire, M., Semsarian, C., Medi, C.
(2014). Late positive flecainide challenge test for
Brugada syndrome. Heart Rhythm, 11(5),
898-900. <a
href="http://dx.doi.org/10.1016/j.hrthm.2014.02.
020">[More Information]</a>
Spirito, P., Autore, C., Formisano, F., Gabriele,
E., Biagini, E., Haas, T., Bongioanni, S.,
Semsarian, C., Devoto, E., Musumeci, B.,
Yeates, L., et al (2014). Risk of sudden death and
outcome in patients with hypertrophic
cardiomyopathy with benign presentation and
without risk factors. The American Journal of
Cardiology, 113(9), 1550-1555. <a
href="http://dx.doi.org/10.1016/j.amjcard.2014.0
1.435">[More Information]</a>
Semsarian, C., Sweeting, J., Ingles, J. (2014).
Sudden death in athletes: Preventable or
inevitable? Heart Rhythm, 11(10), 1682-1683. <a
href="http://dx.doi.org/10.1016/j.hrthm.2014.05.
039">[More Information]</a>
Publications for Christopher Semsarian
Ingles, J., Semsarian, C. (2014). The value of
cardiac genetic testing. Trends In Cardiovascular
Medicine, 24(6), 217-224. <a
href="http://dx.doi.org/10.1016/j.tcm.2014.05.00
9">[More Information]</a>
2013
Tsoutsman, T., Wang, X., Garchow, K., Riser,
B., Twigg, S., Semsarian, C. (2013). CCN2 plays
a key role in extracellular matrix gene expression
in severe hypertrophic cardiomyopathy and heart
failure. Journal of Molecular and Cellular
Cardiology, 62, 164-178. <a
href="http://dx.doi.org/10.1016/j.yjmcc.2013.05.
019">[More Information]</a>
Ingles, J., Sarina, T., Yeates, L., Hunt, L.,
Macciocca, I., McCormack, L., Winship, I.,
McGaughran, J., Atherton, J., Semsarian, C.
(2013). Clinical predictors of genetic testing
outcomes in hypertrophic cardiomyopathy.
Genetics in Medicine, 15(12), 972-977. <a
href="http://dx.doi.org/10.1038/gim.2013.44">[
More Information]</a>
Semsarian, C., Ingles, J. (2013). Expanding the
genetic spectrum of hypertrophic
cardiomyopathy: x marks the spot. Circulation
Cardiovascular Genetics, 6(6), 528-530. <a
href="http://dx.doi.org/10.1161/CIRCGENETIC
S.113.000377">[More Information]</a>
Costa, M., Guo, G., Wolstein, O., Vale, M.,
Castro, M., Wang, L., Otway, R., Riek, R.,
Cochrane, N., Furtado, M., Semsarian, C., et al
(2013). Functional characterization of a novel
mutation in NKX2-5 associated with congenital
heart disease and adult-onset cardiomyopathy.
Circulation Cardiovascular Genetics, 6(3),
238-247. <a
href="http://dx.doi.org/10.1161/CIRCGENETIC
S.113.000057">[More Information]</a>
Ingles, J., Yeates, L., Hunt, L., McGaughran, J.,
Scuffham, P., Atherton, J., Semsarian, C. (2013).
Health status of cardiac genetic disease patients
and their at-risk relatives. International Journal
of Cardiology, 165(3), 448-453. <a
href="http://dx.doi.org/10.1016/j.ijcard.2011.08.
083">[More Information]</a>
Gray, B., Yeates, L., Medi, C., Ingles, J.,
Semsarian, C. (2013). Homozygous mutation in
the cardiac troponin I gene: Clinical
heterogeneity in hypertrophic cardiomyopathy.
International Journal of Cardiology, 168(2),
1530-1531. <a
href="http://dx.doi.org/10.1016/j.ijcard.2012.12.
008">[More Information]</a>
Huang, M., Sivagurunathan, S., Ting, S.,
Jansson, P., Austin, C., Kelly, M., Semsarian, C.,
Zhang, D., Richardson, D. (2013). Molecular and
Functional Alterations in a Mouse Cardiac
Model of Friedreich Ataxia: Activation of the
Integrated Stress Response, eIF2a
Phosphorylation, and the Induction of
Downstream Targets. The American Journal of
Pathology, 183(3), 745-757. <a
href="http://dx.doi.org/10.1016/j.ajpath.2013.05.
032">[More Information]</a>
Figtree, G., Bagnall, R., Abdulla, I., Buchholz,
S., Galougahi, K., Yan, W., Tan, T., Neil, C.,
Horowitz, J., Semsarian, C., Ward, M. (2013).
No association of G-protein-coupled receptor
kinase 5 or β-adrenergic receptor polymorphisms
with Takotsubo cardiomyopathy in a large
Australian cohort. European Journal of Heart
Failure, 15(7), 730-733. <a
href="http://dx.doi.org/10.1093/eurjhf/hft040">[
More Information]</a>
Semsarian, C., Weintraub, R. (2013). Paediatric
cardiomyopathy: Getting to the heart of the
matter. The Lancet, 382(9908), 1866-1867. <a
href="http://dx.doi.org/10.1016/S0140-6736(13)
61799-7">[More Information]</a>
Yeates, L., Hunt, L., Saleh, M., Semsarian, C.,
Ingles, J. (2013). Poor psychological wellbeing
particularly in mothers following sudden cardiac
death in the young. European Journal of
Cardiovascular Nursing, 12(5), 484-491. <a
href="http://dx.doi.org/10.1177/1474515113485
510">[More Information]</a>
Sweeting, J., Duflou, J., Semsarian, C. (2013).
Postmortem analysis of cardiovascular deaths in
schizophrenia: A 10-year review. Schizophrenia
Research, 150(2-3), 398-403. <a
href="http://dx.doi.org/10.1016/j.schres.2013.08.
029">[More Information]</a>
Evans, A., Bagnall, R., Duflou, J., Semsarian, C.
(2013). Postmortem review and genetic analysis
in sudden infant death syndrome: an 11-year
review. Human Pathology, 44(9), 1730-1736. <a
href="http://dx.doi.org/10.1016/j.humpath.2013.
01.024">[More Information]</a>
Maron, B., Spirito, P., Ackerman, M., Casey, S.,
Semsarian, C., Estes, N., Shannon, K., Ashley,
E., Day, S., Pacileo, G., et al (2013). Prevention
of Sudden Cardiac Death With Implantable
Cardioverter-Defibrillators in Children and
Adolescents With Hypertrophic
Cardiomyopathy. Journal of the American
College of Cardiology, 61(14), 1527-1535. <a
href="http://dx.doi.org/10.1016/j.jacc.2013.01.03
7">[More Information]</a>
Gray, B., Ingles, J., Medi, C., Semsarian, C.
(2013). Prolongation of the QTc Interval Predicts
Appropriate Implantable
Cardioverter-Defibrillator Therapies in
Hypertrophic Cardiomyopathy. JACC: Heart
Failure, 1(2), 149-155. <a
href="http://dx.doi.org/10.1016/j.jchf.2013.01.00
Publications for Christopher Semsarian
4">[More Information]</a>
Ingles, J., Sarina, T., Kasparian, N., Semsarian,
C. (2013). Psychological wellbeing and
posttraumatic stress associated with implantable
cardioverter defibrillator therapy in young adults
with genetic heart disease. International Journal
of Cardiology, 168(4), 3779-3784. <a
href="http://dx.doi.org/10.1016/j.ijcard.2013.06.
006">[More Information]</a>
Ingles, J., Semsarian, C. (2013). The Australian
Genetic Heart Disease Registry. International
Journal of Cardiology, 168(4), e127-e128. <a
href="http://dx.doi.org/10.1016/j.ijcard.2013.08.
036">[More Information]</a>
Padang, R., Bannon, P., Jeremy, R., Richmond,
D., Semsarian, C., Vallely, M., Wilson, M., Yan,
T. (2013). The genetic and molecular basis of
bicuspid aortic valve associated thoracic
aortopathy: a link to phenotype heterogeneity.
Annals of Cardiothoracic Surgery, 2(1), 83-91.
<a
href="http://dx.doi.org/10.3978/j.issn.2225-319X
.2012.11.17">[More Information]</a>
Offen, S., Celermajer, D., Semsarian, C.,
Puranik, R. (2013). The role of diastolic filling in
preserving left ventricular stroke volume - An
MRI study. International Journal of Cardiology,
168(2), 1596-1598. <a
href="http://dx.doi.org/10.1016/j.ijcard.2013.01.
039">[More Information]</a>
Redfern, J., Ingles, J., Neubeck, A., Johnston, S.,
Semsarian, C. (2013). Tweeting Our Way to
Cardiovascular Health. Journal of the American
College of Cardiology, 61(15), 1657-1658. <a
href="http://dx.doi.org/10.1016/j.jacc.2013.01.04
1">[More Information]</a>
Alsheikh-Ali, A., Link, M., Semsarian, C., Shen,
W., Mark Estes lll, N., Maron, M., Haas, T.,
Formisano, F., Boriani, G., Spirito, P., et al
(2013). Ventricular tachycardia/fibrillation early
after defibrillator implantation in patients with
hypertrophic cardiomyopathy is explained by a
high-risk subgroup of patients. Heart Rhythm,
10(2), 214-218. <a
href="http://dx.doi.org/10.1016/j.hrthm.2012.10.
003">[More Information]</a>
2012
Ingles, J., McGaughran, J., Scuffham, P.,
Atherton, J., Semsarian, C. (2012). A
cost-effectiveness model of genetic testing for
the evaluation of families with hypertrophic
cardiomyopathy. Heart, 98(8), 625-630. <a
href="http://dx.doi.org/10.1136/heartjnl-2011-30
0368">[More Information]</a>
Watts, G., Sullivan, D., van Bockxmeer, F.,
Poplawski, N., Hamilton-Craig, I., Clifton, P.,
O'Brien, R., Bishop, W., George, P., Semsarian,
C., et al (2012). A New Model of Care for
Familial Hypercholesterolaemia: What is the
Role of Cardiology? Heart, Lung and
Circulation, 21(9), 543-550. <a
href="http://dx.doi.org/10.1016/j.hlc.2012.04.01
0">[More Information]</a>
Gray, B., Das K, J., Semsarian, C. (2012).
Consumption of energy drinks: A new
provocation test for primary arrhythmogenic
diseases? International Journal of Cardiology,
159(1), 77-78. <a
href="http://dx.doi.org/10.1016/j.ijcard.2012.05.
121">[More Information]</a>
Maron, B., Maron, M., Semsarian, C. (2012).
Double or compound sarcomere mutations in
hypertrophic cardiomyopathy: a potential link to
sudden death in the absence of conventional risk
factors. Heart Rhythm, 9(1), 57-63. <a
href="http://dx.doi.org/10.1016/j.hrthm.2011.08.
009">[More Information]</a>
Padang, R., Bagnall, R., Semsarian, C. (2012).
Genetic Basis of Familial Valvular Heart
Disease. Circulation: Cardiovascular Genetics,
5(5), 569-580. <a
href="http://dx.doi.org/10.1161/CIRCGENETIC
S.112.962894">[More Information]</a>
Ingles, J., Yeates, L., O'Brien, L., McGaughran,
J., Scuffham, P., Atherton, J., Semsarian, C.
(2012). Genetic testing for inherited heart
diseases: longitudinal impact on health-related
quality of life. Genetics in Medicine, 14(8),
749-752. <a
href="http://dx.doi.org/10.1038/gim.2012.47">[
More Information]</a>
Maron, B., Maron, M., Semsarian, C. (2012).
Genetics of hypertrophic cardiomyopathy after
20 years: clinical perspectives. Journal of the
American College of Cardiology, 60(8), 705-715.
<a
href="http://dx.doi.org/10.1016/j.jacc.2012.02.06
8">[More Information]</a>
Bagnall, R., Tsoutsman, T., Shephard, R.,
Ritchie, W., Semsarian, C. (2012). Global
MicroRNA Profiling of the Mouse Ventricles
during Development of Severe Hypertrophic
Cardiomyopathy and Heart Failure. PloS One,
7(9), 1-8. <a
href="http://dx.doi.org/10.1371/journal.pone.004
4744">[More Information]</a>
Semsarian, C., Hamilton, R. (2012). Key role of
the molecular autopsy in sudden unexpected
death. Heart Rhythm, 9(1), 145-150. <a
href="http://dx.doi.org/10.1016/j.hrthm.2011.07.
034">[More Information]</a>
Maron, B., Semsarian, C. (2012). Prevention of
sudden death for patients with cardiomyopathies
another step forward. Journal of the American
Publications for Christopher Semsarian
College of Cardiology, 59(5), 501-502. <a
href="http://dx.doi.org/10.1016/j.jacc.2011.10.86
9">[More Information]</a>
Padang, R., Bagnall, R., Richmond, D., Bannon,
P., Semsarian, C. (2012). Rare non-synonymous
variations in the transcriptional activation
domains of GATA5 in bicuspid aortic valve
disease. Journal of Molecular and Cellular
Cardiology, 53(2), 277-281. <a
href="http://dx.doi.org/10.1016/j.yjmcc.2012.05.
009">[More Information]</a>
Neubeck, A., Lowres, N., Semsarian, C., Ingles,
J., Johnston, S., Redfern, J. (2012). Social Media
and Cardiac Rehabilitation: A Systematic
Review. 22nd Australian Cardiovascular Health
and Rehabilitation Association (ACRA) Annual
Conference 2012, Brisbane, Queensland,
Australia.
2011
Kelly, M., Bagnall, R., Peverill, R., Donelan, L.,
Corben, L., Delatycki, M., Semsarian, C. (2011).
A polymorphic miR-155 binding site in AGTR1
is associated with cardiac hypertrophy in
Friedreich ataxia. Journal of Molecular and
Cellular Cardiology, 51(5), 848-854. <a
href="http://dx.doi.org/10.1016/j.yjmcc.2011.07.
001">[More Information]</a>
Vohra, J., Skinner, J., Semsarian, C. (2011).
Cardiac Genetic Investigation of Young Sudden
Unexplained Death and Resuscitated Out of
Hospital Cardiac Arrest. Heart, Lung and
Circulation, 20(12), 746-750. <a
href="http://dx.doi.org/10.1016/j.hlc.2011.07.01
5">[More Information]</a>
Maron, B., Yeates, L., Semsarian, C. (2011).
Clinical challenges of genotype positive
(+)phenotype negative (-) family members in
hypertrophic cardiomyopathy. The American
Journal of Cardiology, 107(4), 604-608. <a
href="http://dx.doi.org/10.1016/j.amjcard.2010.1
0.022">[More Information]</a>
Eshoo, S., Semsarian, C., Ross, D., Marwick, T.,
Thomas, L. (2011). Comparison of Left Atrial
Phasic Function in Hypertrophic
Cardiomyopathy Versus Systemic Hypertension
Using Strain Rate Imaging. The American
Journal of Cardiology, 107(2), 290-296. <a
href="http://dx.doi.org/10.1016/j.amjcard.2010.0
8.071">[More Information]</a>
Tu, E., Waterhouse, L., Duflou, J., Bagnall, R.,
Semsarian, C. (2011). Genetic Analysis of
Hyperpolarization-Activated Cyclic
Nucleotide-Gated Cation Channels in Sudden
Unexpected in Epilepsy Cases. Brain Pathology,
21(6), 692-698. <a
href="http://dx.doi.org/10.1111/j.1750-3639.201
1.00500.x">[More Information]</a>
Maron, B., Ahluwalia, A., Haas, T., Semsarian,
C., Link, M., Estes, N. (2011). Global
epidemiology and demographics of commotio
cordis. Heart Rhythm, 8(12), 1969-1971. <a
href="http://dx.doi.org/10.1016/j.hrthm.2011.07.
014">[More Information]</a>
Ingles, J., Zodgekar, P., Yeates, L., Macciocca,
I., Semsarian, C., Fatkin, D., Members of
CSANZ Cardiac Genetic Diseases Council
Writing Group, M. (2011). Guidelines for
genetic testing of inherited cardiac disorders.
Heart, Lung and Circulation, 20(11), 681-687.
<a
href="http://dx.doi.org/10.1016/j.hlc.2011.07.01
3">[More Information]</a>
Semsarian, C., Members of CSANZ Cardiac
Genetic Diseases Council Writing Group, M.
(2011). Guidelines for the diagnosis and
management of hypertrophic cardiomyopathy.
Heart, Lung and Circulation, 20(11), 688-690.
<a
href="http://dx.doi.org/10.1016/j.hlc.2011.07.01
7">[More Information]</a>
Ackerman, M., Priori, S., Willems, S., Berul, C.,
Brugada, R., Calkins, H., Camm, A., Ellinor, P.,
Gollob, M., et al, Semsarian, C. (2011).
HRS/EHRA expert consensus statement on the
state of genetic testing for the channelopathies
and cardiomyopathies. Europace, 13(8),
1077-1109. <a
href="http://dx.doi.org/10.1093/europace/eur245
">[More Information]</a>
Gray, B., Semsarian, C., Sy, R., Jeremy, R.
(2011). Left coronary artery fistula after septal
myectomy in hypertrophic cardiomyopathy.
Heart, Lung and Circulation, 20(11), 738-738.
<a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=22106468">[More Information]</a>
Bagnall, R., Ingles, J., Semsarian, C. (2011).
Molecular diagnostics of cardiomyopathies: the
future is here. Circulation Cardiovascular
Genetics, 4(2), 103-104. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=21505198">[More Information]</a>
Gray, B., Ingles, J., Semsarian, C. (2011).
Natural history of genotype positive-phenotype
negative patients with hypertrophic
cardiomyopathy. International Journal of
Cardiology, 152(2), 258-259. <a
href="http://dx.doi.org/10.1016/j.ijcard.2011.07.
095">[More Information]</a>
Ng, D., Ng, I., Yeap, Y., Badrain, B., Tsoutsman,
T., McMullen, J., Semsarian, C., Bogoyevitch,
M. (2011). Opposing Actions of Extracellular
Signal-Regulated Kinase (ERK) and Signal
Publications for Christopher Semsarian
Transducer and Activator of Transcription 3
(STAT3) in Regulating Microtubule Stabilization
during Cardiac Hypertrophy. Journal of
Biological Chemistry, 286(2), 1576-1587. <a
href="http://dx.doi.org/10.1074/jbc.M110.12815
7">[More Information]</a>
Boase, N., Rychkov, G., Townley, S., Dinudom,
A., Candi, E., Voss, A., Tsoutsman, T.,
Semsarian, C., Melino, G., Koentgen, F., Cook,
D., et al (2011). Respiratory distress and
perinatal lethality in Nedd4-2-deficient mice.
Nature Communications, 2(1), 1-9. <a
href="http://dx.doi.org/10.1038/ncomms1284">[
More Information]</a>
Ingles, J., Yeates, L., Semsarian, C. (2011). The
emerging role of the cardiac genetic counselor.
Heart Rhythm, 8(12), 1958-1962. <a
href="http://dx.doi.org/10.1016/j.hrthm.2011.07.
017">[More Information]</a>
Qian, L., Wythe, J., Liu, J., Cartry, J., Vogler, G.,
Mohapatra, B., Otway, R., Huang, Y., King, I.,
Maillet, M., Semsarian, C., Winlaw, D., et al
(2011). Tinman/Nkx2-5 acts via miR-1 and
upstream of Cdc42 to regulate heart function
across species. The Journal of Cell Biology,
193(7), 1181-1196. <a
href="http://dx.doi.org/10.1083/jcb.201006114">
[More Information]</a>
2010
Bagnall, R., Yeates, L., Semsarian, C. (2010).
Analysis of the Z-disc genes PDLIM3 and
MYPN in Patients with Hypertrophic
Cardiomyopathy. International Journal of
Cardiology, 145(3), 601-2. <a
href="http://dx.doi.org/10.1016/j.ijcard.2010.08.
004">[More Information]</a>
Girolami, F., Ho, C., Semsarian, C., Baldi, M.,
Will, M., Baldini, K., Torricelli, F., Yeates, L.,
Cecchi, F., Ackerman, M., et al (2010). Clinical
features and outcome of hypertrophic
cardiomyopathy associated with triple sarcomere
protein gene mutations. Journal of the American
College of Cardiology, 55(14), 1444-1453. <a
href="http://dx.doi.org/10.1016/j.jacc.2009.11.06
2">[More Information]</a>
Lam, L., Tsoutsman, T., Arthur, J., Semsarian, C.
(2010). Differential protein expression profiling
of myocardial tissue in a mouse model of
hypertrophic cardiomyopathy. Journal of
Molecular and Cellular Cardiology, 48(5),
1014-1022. <a
href="http://dx.doi.org/10.1016/j.yjmcc.2009.08.
015">[More Information]</a>
Maron, B., Semsarian, C. (2010). Emergence of
gene mutation carriers and the expanding disease
spectrum of hypertrophic cardiomyopathy.
European Heart Journal, 31(13), 1551-1553. <a
href="http://dx.doi.org/10.1093/eurheartj/ehq111
">[More Information]</a>
Eshoo, S., Semsarian, C., Ross, D., Thomas, L.
(2010). Left Atrial Phasic Volumes Are
Modulated by the Type Rather Than the Extent
of Left Ventricular Hypertrophy. Journal of the
American Society of Echocardiography, 23(5),
538-544. <a
href="http://dx.doi.org/10.1016/j.echo.2010.01.0
22">[More Information]</a>
Chiu, C., Bagnall, R., Ingles, J., Yeates, L.,
Kennerson, M., Donald, J., Jormakka, M., Lind,
J., Semsarian, C. (2010). Mutations in
Alpha-Actinin-2 Cause Hypertrophic
Cardiomyopathy: A Genome-Wide Analysis.
Journal of the American College of Cardiology,
55(11), 1127-1135. <a
href="http://dx.doi.org/10.1016/j.jacc.2009.11.01
6">[More Information]</a>
Tu, E., Bagnall, R., Duflou, J., Lynch, M.,
Twigg, S., Semsarian, C. (2010). Post-mortem
pathologic and genetic studies in "dead in bed
syndrome" cases in type 1 diabetes mellitus.
Human Pathology, 41(3), 392-400. <a
href="http://dx.doi.org/10.1016/j.humpath.2009.
08.020">[More Information]</a>
Tu, E., Bagnall, R., Duflou, J., Semsarian, C.
(2010). Post-Mortem Review and Genetic
Analysis of Sudden Unexpected Death in
Epilepsy (SUDEP) Cases. Brain Pathology, ,
1-8. <a
href="http://dx.doi.org/10.1111/j.1750-3639.201
0.00438.x">[More Information]</a>
Tu, E., Twigg, S., Semsarian, C. (2010). Sudden
death in type 1 diabetes: The mystery of the
'dead in bed' syndrome. International Journal of
Cardiology, 138(1), 91-93. <a
href="http://dx.doi.org/10.1016/j.ijcard.2008.06.
021">[More Information]</a>
2009
Shepard, R., Semsarian, C. (2009). Advances in
the prevention of sudden cardiac death in the
young. Therapeutic Advances in Cardiovascular
Disease, 3(2), 145-155. <a
href="http://dx.doi.org/10.1177/1753944708100
181">[More Information]</a>
Wang, X., McLennan, S., Allen, T., Tsoutsman,
T., Semsarian, C., Twigg, S. (2009). Adverse
effects of high glucose and free fatty acid on
cardiomyocytes are mediated by connective
tissue growth factor. American Journal of
Physiology: Cell Physiology, 297(6),
c1490-c1500. <a
href="http://dx.doi.org/10.1152/ajpcell.00049.20
09">[More Information]</a>
Maron, B., Semsarian, C., Shen, W., Link, M.,
Epstein, A., Estes, N., Almquist, A., Giudici, M.,
Publications for Christopher Semsarian
Haas, T., Hodges, J., et al (2009). Circadian
patterns in the occurrence of malignant
ventricular tachyarrhythmias triggering
defibrillator interventions in patients with
hypertrophic cardiomyopathy. Heart Rhythm,
6(5), 599-602. <a
href="http://dx.doi.org/10.1016/j.hrthm.2009.02.
007">[More Information]</a>
Kelly, M., Semsarian, C. (2009). Multiple
mutations in genetic cardiovascular disease: a
marker of disease severity? Circulation:
Cardiovascular Genetics, 2(2), 182-190. <a
href="http://dx.doi.org/10.1161/CIRCGENETIC
S.108.836478">[More Information]</a>
Wilcox, I., Semsarian, C. (2009). Obstructive
sleep apnea a respiratory syndrome with protean
cardiovascular manifestations. Journal of the
American College of Cardiology, 54(19),
1810-1812. <a
href="http://dx.doi.org/10.1016/j.jacc.2009.06.03
9">[More Information]</a>
Sherrid, M., Cotiga, D., Hart, D., Ehlert, F.,
Haas, T., Shen, W., Link, M., Estes, N., Epstein,
A., et al, Semsarian, C. (2009). Relation of
12-lead electrocardiogram patterns to implanted
defibrillator-terminated ventricular
tachyarrhythmias in hypertrophic
cardiomyopathy. The American Journal of
Cardiology, 104(12), 1722-1726. <a
href="http://dx.doi.org/10.1016/j.amjcard.2009.0
7.056">[More Information]</a>
Shephard, R., Semsarian, C. (2009). Role of
animal models in HCM research. Journal of
Cardiovascular Translational Research, 2(4),
471-482. <a
href="http://dx.doi.org/10.1007/s12265-009-912
0-y">[More Information]</a>
Bagnall, R., Yeates, L., Semsarian, C. (2009).
The role of large gene deletions and duplications
in MYBPC3 and TNNT2 in patients with
hypertrophic cardiomyopathy. International
Journal of Cardiology, 145, 150-3. <a
href="http://dx.doi.org/10.1016/j.ijcard.2009.07.
009">[More Information]</a>
Semsarian, C. (2009). Use of mouse models for
the analysis of human disease. Current Protocols
in Human Genetics, , 15.2.1-15.2.10. <a
href="http://dx.doi.org/10.1002/0471142905.hg1
502s60">[More Information]</a>
2008
Tu, E., Twigg, S., Duflou, J., Semsarian, C.
(2008). Causes of death in young Australians
with type 1 diabetes: a review of coronial
postmortem examinations. Medical Journal of
Australia, 188(12), 699-702. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=18558891">[More Information]</a>
Ingles, J., McGaughran, J., Vohra, J., Weintraub,
R., Davis, A., Atherton, J., Semsarian, C. (2008).
Establishment of an Australian National Genetic
Heart Disease Registry. Heart, Lung and
Circulation, 17(6), 463-467. <a
href="http://dx.doi.org/10.1016/j.hlc.2008.05.60
3">[More Information]</a>
Tsoutsman, T., Bagnall, R., Semsarian, C.
(2008). Impact of multiple gene mutations in
determining the severity of cardiomyopathy and
heart failure. Clinical and Experimental
Pharmacology and Physiology, 35(11),
1349-1357. <a
href="http://dx.doi.org/10.1111/j.1440-1681.200
8.05037.x">[More Information]</a>
Vallely, M., Semsarian, C., Bannon, P. (2008).
Management of the Ascending Aorta in Patients
with Bicuspid Aortic Valve Disease. Heart, Lung
and Circulation, 17(5), 357-363. <a
href="http://dx.doi.org/10.1016/j.hlc.2008.01.00
7">[More Information]</a>
Doolan, A., Langlois, N., Chiu, C., Ingles, J.,
Lind, J., Semsarian, C. (2008). Postmortem
molecular analysis of KCNQ1 and SCN5A genes
in sudden unexplained death in young
Australians. International Journal of Cardiology,
127, 138-141. <a
href="http://dx.doi.org/10.1016/j.ijcard.2007.05.
001">[More Information]</a>
Ingles, J., Lind, J., Phongsavan, P., Semsarian, C.
(2008). Psychosocial impact of specialized
cardiac genetic clinics for hypertrophic
cardiomyopathy. Genetics in Medicine, 10(2),
117-120. <a
href="http://dx.doi.org/10.1097/GIM.0b013e318
1612cc7">[More Information]</a>
Skinner, J., Duflou, J., Semsarian, C. (2008).
Reducing sudden death in young people in
Australia and New Zealand: The TRAGADY
initiative. Medical Journal of Australia, 189(10),
539-540. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=19012547">[More Information]</a>
Tsoutsman, T., Kelly, M., Ng, D., Tan, J., Tu, E.,
Lien, L., Bogoyevitch, M., Seidman, C.,
Seidman, J., Semsarian, C. (2008). Severe heart
failure and early mortality in a double-mutation
mouse model of familial hypertrophic
cardiomyopathy. Circulation, 117(14),
1820-1831. <a
href="http://dx.doi.org/10.1161/CIRCULATION
AHA.107.755777">[More Information]</a>
Lind, J., Chiu, C., Ingles, J., Yeates, L.,
Humphries, S., Heather, A., Semsarian, C.
(2008). Sex hormone receptor gene variation
Publications for Christopher Semsarian
associated with phenotype in male hypertrophic
cardiomyopathy patients. Journal of Molecular
and Cellular Cardiology, 45(2), 217-222. <a
href="http://dx.doi.org/10.1016/j.yjmcc.2008.05.
016">[More Information]</a>
2007
Chiu, C., Tebo, M., Ingles, J., Yeates, L., Arthur,
J., Lind, J., Semsarian, C. (2007). Genetic
screening of calcium regulation genes in familial
hypertrophic cardiomyopathy. Journal of
Molecular and Cellular Cardiology, 43,
337-343. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17655857">[More Information]</a>
Semsarian, C. (2007). Guidelines for the
Diagnosis and Management of Hypertrophic
Cardiomyopathy. Heart, Lung and Circulation,
16(1), 16-18. <a
href="http://dx.doi.org/10.1016/j.hlc.2006.10.02
0">[More Information]</a>
Maron, B., Spirito, P., Shen, W., Haas, T.,
Formisano, F., Link, M., Epstein, A., Almquist,
A., Daubert, J., Lawrenz, T., Semsarian, C., et al
(2007). Implantable Cardioverter-Defibrillators
and Prevention of Sudden Cardiac Death in
Hypertrophic Cardiomyopathy. JAMA: The
Journal of the American Medical Association,
298(4), 405-412. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17652294">[More Information]</a>
Lam, L., Arthur, J., Semsarian, C. (2007).
Proteome map of the normal murine ventricular
myocardium. Proteomics, 7(19), 3629-3633. <a
href="http://dx.doi.org/10.1002/pmic.200700312
">[More Information]</a>
Ingles, J., Semsarian, C. (2007). Sudden cardiac
death in the young: a clinical genetic approach.
Internal Medicine Journal, 37(1), 32-37. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17199842">[More Information]</a>
2006
Nguyen, L., Chung, J., Lam, L., Tsoutsman, T.,
Semsarian, C. (2006). Abnormal cardiac
response to exercise in a murine model of
familial hypertrophic cardiomyopathy.
International Journal of Cardiology, , 1-4. <a
href="http://dx.doi.org/10.1016/j.ijcard.2006.09.
001">[More Information]</a>
Lam, L., Lind, J., Semsarian, C. (2006).
Application of proteomics in cardiovascular
medicine. International Journal of Cardiology,
108(1), 12-19. <a
href="http://dx.doi.org/10.1016/j.ijcard.2006.01.
002">[More Information]</a>
Tsoutsman, T., Lam, L., Semsarian, C. (2006).
Genes, calcium and modifying factors in
hypertrophic cardiomyopathy. Clinical and
Experimental Pharmacology and Physiology, 33,
139-145. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16445713">[More Information]</a>
Lind, J., Chiu, C., Semsarian, C. (2006). Genetic
basis of hypertrophic cardiomyopathy. Expert
Review of Cardiovascular Therapy, 4(6),
927-934. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17173506">[More Information]</a>
Tsoutsman, T., Chung, J., Doolan, A., Nguyen,
L., Williams, I., Tu, E., Lam, L., Bailey, C.,
Rasko, J., Allen, D., Semsarian, C. (2006).
Molecular insights from a novel cardiac troponin
I mouse model of familial hypertrophic
cardiomyopathy. Journal of Molecular and
Cellular Cardiology, 41(4), 623-632. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16950368">[More Information]</a>
Tsoutsman, T., Chung, J., Doolan, A., Nguyen,
L., Williams, I., Tu, E., Lam, L., Rasko, J.,
Bailey, C., Allen, D., Semsarian, C. (2006).
Mouse cardiac troponin I model of hypertrophic
cardiomyopathy: Phenotype associated with
abnormal calcium handling. Journal of
Molecular and Cellular Cardiology, 41(4), 747
(abstract 41)-747.
Chiu, C., Ingles, J., Lind, J., Semsarian, C.
(2006). Mutation analysis of the natriuretic
peptide precursor B (NPPB) gene in patients
with hypertrophic cardiomyopathy. DNA
Sequence, 17(5), 392-395. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17343213">[More Information]</a>
Lind, J., Semsarian, C. (2006). Overview of
model systems for the analysis of human disease.
Current Protocols in Human Genetics, , Unit
15.1. <a
href="http://dx.doi.org/10.1002/0471142905.hg1
501s48">[More Information]</a>
2005
Herron, B., Rao, C., Liu, S., Laprade, L.,
Richardson, J., Oliveri, E., Semsarian, C., Millar,
S., Stubbs, L., Beier, D. (2005). A mutation in
NFkB interacting protein 1 results in
cardiomyopathy and abnormal skin development
in wa3 mice. Human Molecular Genetics, 14(5),
667-677. <a
href="http://dx.doi.org/10.1093/hmg/ddi063">[
More Information]</a>
Publications for Christopher Semsarian
Doolan, A., Tebo, M., Ingles, J., Nguyen, L.,
Tsoutsman, T., Lam, L., Chiu, C., Chung, J.,
Weintraub, R., Semsarian, C. (2005). Cardiac
troponin I mutations in Australian families with
hypertrophic cardiomyopathy: clinical, genetic
and functional consequences. Journal of
Molecular and Cellular Cardiology, 38(2),
387-93. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15698845">[More Information]</a>
Ingles, J., Doolan, A., Chiu, C., Seidman, J.,
Seidman, C., Semsarian, C. (2005). Compound
and double mutations in hypertrophic
cardiomyopathy patients: Implications for
genetic testing and counselling. American Heart
Association Annual Scientific Sessions 2005,
United States: American Heart Association.
Ingles, J., Doolan, A., Chiu, C., Seidman, J.,
Seidman, C., Semsarian, C. (2005). Compound
and double mutations in patients with
hypertrophic cardiomyopathy: implications for
genetic testing and counselling. Journal of
Medical Genetics, 42(10), 1-6. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16199542">[More Information]</a>
Megevand, A., Ingles, J., Richmond, D.,
Semsarian, C. (2005). Long-term follow-up of
patients with obstructive hypertrophic
cardiomyopathy treated with dual-chamber
pacing. The American Journal of Cardiology,
95(8), 991-993. <a
href="http://dx.doi.org/10.1016/j.amjcard.2004.1
2.045">[More Information]</a>
Wolf, C., Moskowitz, I., Arno, S., Branco, D.,
Semsarian, C., Bernstein, S., Peterson, M.,
Maida, M., Morley, G., Fishman, G., et al
(2005). Somatic events modify hypertrophic
cardiomyopathy pathology and link hypertrophy
to arrhythmia. Proceedings of the National
Academy of Sciences of the United States of
America (PNAS), 102(50), 18123-18128. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16332958">[More Information]</a>
2004
Doolan, A., Langlois, N., Semsarian, C. (2004).
Causes Of Sudden Cardiac Death In Young
Australians. Medical Journal of Australia,
180(3), 110-112.
Doolan, A., Nguyen, L., Semsarian, C. (2004).
Hypertrophic Cardiomyopathy: From "Heart
Tumour" To A Complex Molecular Genetic
Disorder. Heart, Lung and Circulation, 13(1),
15-25.
Jayatilleke, I., Doolan, A., Ingles, J., McGuire,
M., Booth, V., Richmond, D., Semsarian, C.
(2004). Long-Term Follow-Up Of Implantable
Cardioverter Defibrillator Therapy For
Hypertrophic Cardiomyopathy. The American
Journal of Cardiology, 93(9), 1192-1194. <a
href="http://dx.doi.org/10.1016/j.amjcard.2004.0
1.057">[More Information]</a>
Doolan, G., Nguyen, L., Chung, J., Ingles, J.,
Semsarian, C. (2004). Progression Of Left
Ventricular Hypertrophy And The
Angiotensin-Converting Enzyme Gene
Polymorphism In Hypertrophic Cardiomyopathy.
International Journal of Cardiology, 96(2),
157-163.
2003
Schmitt, J., Semsarian, C., Arad, M., Gannon, J.,
Ahmad, F., Duffy, C., Lee, R., Seidman, C.,
Seidman, J. (2003). Consequences of pressure
overload on sarcomere protein mutation-induced
hypertrophic cardiomypathy. Circulation,
108(9), 1133-1138.
Chung, M., Tsoutsman, T., Semsarian, C. (2003).
Hypertrophic cardiomyopathy: from gene defect
to clinical disease. Cell Research, 13(1), 9-20.
Jayatilleke, I., McGuire, M., Booth, V.,
Richmond, D., Semsarian, C. (2003). Sudden
death prevented in hypertrophic cardiomyopathy.
Heart, Lung and Circulation, 12(3), 196-198.
2002
Semsarian, C. (2002). Stem cells in
cardiovascular disease: from cell
biology to clinical therapy. Internal Medicine
Journal, 32(5-6), 259-265.